Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
about
Generalized immune activation as a direct result of activated CD4+ T cell killingEffect of preventive interventions for malaria on HIV-1 disease progression in non-pregnant adultsEffect of preventive interventions for malaria on HIV-1 disease progression in non-pregnant adultsSoluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infectionFunctional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune SuppressionPurinergic Receptors: Key Mediators of HIV-1 Infection and InflammationNew Insights about Treg and Th17 Cells in HIV Infection and Disease ProgressionImpact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damageMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyIncomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsInduction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsHigh levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treaSoluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIVMechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infectionAccelerated immunodeficiency by anti-CCR5 treatment in HIV infectionImmune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infectionThe anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort StudyAntibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed MacaquesImmune Activation Influences SAMHD1 Expression and Vpx-mediated SAMHD1 Degradation during Chronic HIV-1 InfectionHIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA)Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens.Systematic identification of synergistic drug pairs targeting HIVGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesThe Role of Caveolin 1 in HIV Infection and Pathogenesis."Negative vaccination" by specific CD4 T cell tolerisation enhances virus-specific protective antibody responsesAbundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodiesCo-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocationMucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.Proportions of circulating follicular helper T cells are reduced and correlate with memory B cells in HIV-infected children.Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot studyThe effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants.Accelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence.Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts
P2860
Q21146758-0D1AB24D-394B-4D4C-9054-9E0BED5C046DQ24197548-5C3A016D-DB9C-4F79-A23C-53E2D06EAE98Q24240661-A61C2892-3B2B-41B8-9ED5-CDB26A481628Q24295002-B84B4577-67B2-45B7-9145-737C8AD745E5Q24795912-6BE667EC-F37B-4B79-96FF-93E07049D24EQ26744626-5A691600-E820-40EF-B7D2-0E44197D376FQ26774666-3CEDC153-B1DF-4D6D-B2CC-B116939E2D9AQ26777036-BB779758-470C-4E7A-B9AD-184A8D5AD7D5Q27014077-642C5833-6D29-45F3-9BFD-B005EA8BD3B3Q27015778-39EAF269-3BA4-4261-8E1D-B7DB229DAACAQ27021524-FF0BFBF9-D9DB-4FF7-8B9B-2EF52EF774B5Q27488278-4F8C6F04-13F1-4EFA-9F10-BC216EDF0AD5Q27490328-3C8EDF70-F09E-4E7B-AC53-EAAA34AEDF90Q27690715-F7D68145-A086-46A3-B9F5-3287B99F7D5FQ28069817-186C7A5E-354B-4DBD-99B3-AAA9DA922306Q28081838-8DEE6574-3F03-4469-8302-87DB5F9F1B05Q28475890-2BB4E5C3-6282-42CE-ACF5-4C04284B8544Q28478654-57FAD3E4-8181-4366-BDAB-B588E015F0B2Q28546013-F5B9E307-F7C2-4CDD-92F5-F1B0F00FBC25Q28550552-E02F2F0F-BA39-4E2B-9CDA-370B4BD6D8DCQ28552448-FA227C2C-75B9-422A-AF3C-74D4189131D3Q28589591-12686470-613D-4968-92D2-230373739562Q28741718-4203D114-A117-434E-9A76-7D7D08835F33Q30362489-CF65CF43-8845-4F1B-ABDE-D19830F119A1Q30364999-93E4A672-86AF-4D29-9739-F038823B643FQ30422333-88F4D8FF-6E31-45D4-85E8-28A153A92726Q31066870-3507AC1A-2E3E-4A2D-AE9E-37B906653973Q32183747-725666DE-DEEE-4F3E-8C3F-BEDBD03A4CCEQ33305432-73C00A1C-132F-4B4C-944D-A37F3513FDDEQ33354070-BE4ECC10-8260-435E-BFBD-6C0893582B1FQ33384065-DBCABBEB-2F47-4178-BA52-169E1869F979Q33520335-8D24EE8E-E76D-423F-9AF3-AD86F2F94B8FQ33553358-B0D330A6-6172-44C5-8A1C-D0D6C9BB2430Q33603602-CDDCD503-CE97-473E-A392-A9199D1A92F5Q33605792-0D86A30F-F596-4722-84F8-0ABEB5FF3ABEQ33632786-91E78804-7F67-4E92-A483-5DD7C05DA183Q33651140-AE6F0265-1883-4FD7-9107-8162A4294F5CQ33671468-0405BBCC-BAE9-45A6-9B59-88F5C5035A24Q33680743-96A1ED5D-ACAD-427D-A0C9-13C06B44C8ECQ33707549-7895CE5E-6AD2-4BA7-AC93-9DB1528CE67B
P2860
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@en
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@nl
type
label
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@en
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@nl
prefLabel
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@en
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@nl
P2093
P1433
P1476
Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
@en
P2093
Birgit H B van Benthem
Dörte Hamann
Frank Miedema
Joep M A Lange
Marijke Th L Roos
Mette D Hazenberg
Roel A Coutinho
Sigrid A Otto
P304
P356
10.1097/00002030-200309050-00006
P407
P50
P577
2003-09-01T00:00:00Z